TIDMSPEC
RNS Number : 6859F
Inspecs Group PLC
19 July 2021
19 July 2021
Inspecs Group plc
("Inspecs" the "Company" or "the Group")
Result of AGM
Inspecs Group plc, a leading designer, manufacturer and
distributor of eyewear frames, announces that at the Annual General
Meeting held earlier today, all resolutions were duly passed.
Resolution For Against Withheld Total
votes
cast
Number of % Number % Number
votes of votes of votes
----------- -------- ----------- ------- ----------- -----------
Ordinary resolution
to receive and adopt
the Company's annual
1. accounts and reports 77,124,504 83.88% 14,820,434 16.12% 1,960,678 93,905,616
------------------------------ ----------- -------- ----------- ------- ----------- -----------
Ordinary resolution
to re-elect Lord
MacLaurin as a director
2. of the Company. 78,159,511 97.60% 1,921,749 2.40% 13,824,356 93,905,616
------------------------------ ----------- -------- ----------- ------- ----------- -----------
Ordinary resolution
to re-elect Robin
Totterman as a director
3. of the Company. 93,905,616 100.00% 0 0.00% 0 93,905,616
------------------------------ ----------- -------- ----------- ------- ----------- -----------
Ordinary resolution
to re-elect Christopher
Kay as a director
4. of the Company. 93,905,616 100.00% 0 0.00% 0 93,905,616
------------------------------ ----------- -------- ----------- ------- ----------- -----------
Ordinary resolution
to re-elect Christopher
Hancock as a director
5. of the Company. 71,500,121 80.91% 16,867,834 19.09% 5,537,661 93,905,616
------------------------------ ----------- -------- ----------- ------- ----------- -----------
Ordinary resolution
to re-elect Richard
Peck as a director
6. of the Company. 72,227,206 81.73% 16,140,749 18.27% 5,537,661 93,905,616
------------------------------ ----------- -------- ----------- ------- ----------- -----------
Ordinary resolution
to re-elect Angela
Farrugia as a director
7. of the Company. 87,939,607 97.36% 2,389,026 2.64% 3,576,983 93,905,616
------------------------------ ----------- -------- ----------- ------- ----------- -----------
Ordinary resolution
to re-appoint Ernst
& Young LLP as the
Company's auditors
to hold office from
the conclusion of
this meeting until
the conclusion of
the next meeting,
in accordance with
8. normal practice. 93,178,531 99.23% 727,085 0.77% 0 93,905,616
------------------------------ ----------- -------- ----------- ------- ----------- -----------
Ordinary resolution
to authorise the
directors to determine
the remuneration
9. of the auditors 93,178,531 99.23% 727,085 0.77% 0 93,905,616
------------------------------ ----------- -------- ----------- ------- ----------- -----------
Ordinary resolution
to enable the Company
and each of its subsidiaries
to make political
10. donations and expenditure. 93,177,431 99.22% 728,185 0.78% 0 93,905,616
------------------------------ ----------- -------- ----------- ------- ----------- -----------
Ordinary resolution
to authorise the
directors to allot
ordinary shares in
the Company up to
a maximum nominal
amount of GBP337,636.32
and up to a further
maximum nominal amount
of GBP337,636.32
where the allotment
is in connection
with an offer by
11. way of a rights issue. 93,178,531 99.23% 727,085 0.77% 0 93,905,616
------------------------------ ----------- -------- ----------- ------- ----------- -----------
Special resolution
to enable the directors
to allot, grant options
over or otherwise
dispose of equity
securities for cash
or sell treasury
shares for cash up
to a maximum aggregate
nominal amount of
GBP50,645.44 as if
pre-emption rights
did not apply to
12. such allotment. 91,904,493 97.87% 2,001,123 2.13% 0 93,905,616
------------------------------ ----------- -------- ----------- ------- ----------- -----------
Special Resolution
to further disapply
pre-emption rights
in relation to acquisitions
or other capital
13. investments. 91,904,493 97.87% 2,001,123 2.13% 0 93,905,616
------------------------------ ----------- -------- ----------- ------- ----------- -----------
Special resolution
to authorise the
Company to make market
purchases of up to
10,129,089 ordinary
shares (which represents
approximately 10
per cent of the Company's
ordinary shares (excluding
treasury shares)
in issue on 23 June
14. 2021). 93,178,531 99.23% 727,085 0.77% 0 93,905,616
------------------------------ ----------- -------- ----------- ------- ----------- -----------
For further information please contact:
Inspecs Group plc via FTI Consulting
Robin Totterman (CEO) Tel: +44 (0) 20
Chris Kay (CFO) 3727 1000
Peel Hunt (Nominated Adviser and Broker) Tel: +44 (0) 20
Adrian Trimmings 7418 8900
Andrew Clark
FTI Consulting (Financial PR) Tel: +44 (0) 20
Alex Beagley 3727 1000
Fern Duncan
Alice Newlyn
About Inspecs Group plc
INSPECS is a Bath-based designer, manufacturer and distributor
of eyewear frames and optically advanced spectacle lenses. The
Group produces a broad range of frames and lenses, covering
optical, sunglasses and safety, which are either "Branded" (either
under licence or under the Group's own proprietary brands), or
"OEM" (including private label on behalf of retail customers and
un-branded).
In December 2020, INSPECS acquired Eschenbach Optik, a leading,
global, eyewear supplier headquartered in Nuremberg, Germany, which
includes the American company Tura. The acquisition extended the
Group's presence internationally in key global markets. This
followed the acquisition of lens maker Norville in July 2020,
whereby INSPECS combined two heritage brands in British optical,
Savile Row frame maker, and Norville lens maker, further enhancing
its vertically integrated business model. As one of only a few
companies that can offer this one-stop-shop solution to global
retail chains, INSPECS is well positioned to continue to take
market share in the globally expanding eyewear market.
INSPECS customers include global optical and non-optical
retailers, global distributors and independent opticians, with its
distribution network covering over 80 countries and reaching
approximately 70,000 points of sale.
INSPECS has operations across the globe: with offices in the UK,
Portugal, Scandinavia, the US and China (Hong Kong, Macau and
Shenzhen), and manufacturing facilities in Vietnam, China, the UK
and Italy. With the acquisition of Eschenbach Optik, the Group's
international reach further extends across Europe and the American
markets.
The Group's growth strategy going forward is to: (i) continue to
grow organically; (ii) undertake further acquisitions (and drive
value through leveraging the Group's internal capabilities); and
(iii) extend the Group's manufacturing capacity.
More information is available at: https://inspecs.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
RAGUKSRRARUBAAR
(END) Dow Jones Newswires
July 19, 2021 06:42 ET (10:42 GMT)
Inspecs (LSE:SPEC)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Inspecs (LSE:SPEC)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024
